Trulieve Expects at Least $225 Million in 2026 Operating Cash Flow
The company raised its capital spending outlook to about $105 million from $95 million. Management expects low-single-digit fourth-quarter revenue growth, with promotions potentially pressuring margins.

Trulieve Cannabis Corp. expects at least $225 million in operating cash flow in 2026 and plans higher capital spending, setting a cash-generation target alongside investment in expansion markets.
Management expects about $105 million in capital expenditures for 2026, up from $95 million. Planned investment is focused on growth markets, including Georgia and Texas, pending final licensure.
Trulieve generated $183 million in operating cash flow and $120 million in non-GAAP free cash flow during the first nine months of 2026.
Management expects fourth-quarter revenue to grow at a low-single-digit rate and says promotions may pressure margins.